After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that ...

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

The oncology drug created by Isomorphic Labs using Google DeepMind’s AlphaFold 3 tool could be pivotal for cancer treatment.

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

Google DeepMind's Gemini AI won a gold medal at the International Mathematical Olympiad by solving complex math problems ...

A general view of the Google DeepMind offices after the announcement that Founder and CEO Demis Hassabis and senior research scientist, John M. Jumper, received the 2024 Nobel Prize for Chemistry ...

Google's DeepMind research division claims its newest AI agent marks a significant step toward using the technology to tackle big problems in math and science. The system, known as AlphaEvolve, is ...